Comparison of Immune Response Following Surgical Management of Renal Tumors
Condition(s):Kidney CancerLast Updated:September 24, 2013Terminated
Hide Studies Not Open or Pending
Condition(s):Kidney CancerLast Updated:September 24, 2013Terminated
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:October 12, 2015Completed
Condition(s):Immune Response to 3 ApproachesLast Updated:April 19, 2021Terminated
Condition(s):Metastatic Renal Cell Cancer; Malignant Melanoma, MetastaticLast Updated:February 26, 2021Unknown status
Condition(s):Carcinoma, Renal CellLast Updated:October 19, 2020Completed
Condition(s):Recurrent Renal Cell Cancer; Stage IV Renal Cell CancerLast Updated:July 22, 2022Completed
Condition(s):Non Small Cell Lung Cancer; Renal Cell CarcinomaLast Updated:November 17, 2020Withdrawn
Condition(s):Metastatic Renal Cell Carcinoma; Metastatic MelanomaLast Updated:June 8, 2021Completed
Condition(s):Kidney CancerLast Updated:August 1, 2017Terminated
Condition(s):Bladder Cancer; Kidney Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral CancerLast Updated:July 5, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.